Stephen Bardin - 13 Nov 2024 Form 3 Insider Report for CalciMedica, Inc. (CALC)

Role
Chief Financial Officer
Signature
/s/ John Dunn, Esq., Attorney-in-Fact
Issuer symbol
CALC
Transactions as of
13 Nov 2024
Net transactions value
$0
Form type
3
Filing time
15 Nov 2024, 16:04:55 UTC
Previous filing
16 Mar 2023
Next filing
25 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CALC Common Stock 40,000 13 Nov 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CALC Employee Stock Option (Right to Buy) 13 Nov 2024 Common Stock 5,000 $5.45 Direct F2
holding CALC Employee Stock Option (Right to Buy) 13 Nov 2024 Common Stock 100,000 $3.50 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2023 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. 1/4th of the shares subject to the RSU shall vest on October 1, 2025, and 1/16th of the total shares subject to the RSU shall vest on every three months thereafter over the next three years.
F2 Immediately Exercisable.
F3 1/4th of the shares subject to the Option shall vest on October 1, 2025, and 1/48th of the total shares subject to the Option shall vest on each monthly anniversary thereafter over the next three years.